Search research articles
Contact Us
Filters
Showing results (1-10 of 9) with videos related to
Page
of 1
Sort By:
Methods in Molecular Biology (Clifton, N.J.)
|
December 31, 2015
Modeling HIV-1 Mucosal Transmission and Prevention in Humanized Mice
Milena Veselinovic, Paige Charlins, Ramesh Akkina
Virology
|
July 27, 2012
Topical gel formulation of broadly neutralizing anti-HIV-1 monoclonal antibody VRC01 confers protection against HIV-1 vaginal challenge in a humanized mouse model
Milena Veselinovic, C Preston Neff, Leila R Mulder, et al.
Biosensors & Bioelectronics
|
September 14, 2016
A sensitive DNA capacitive biosensor using interdigitated electrodes
Lei Wang, Milena Veselinovic, Lang Yang, et al.
Virology
|
January 16, 2016
Mucosal tissue pharmacokinetics of the integrase inhibitor raltegravir in a humanized mouse model: Implications for HIV pre-exposure prophylaxis
Milena Veselinovic, Kuo-Hsiung Yang, Craig Sykes, et al.
Virology
|
August 9, 2014
HIV pre-exposure prophylaxis: mucosal tissue drug distribution of RT inhibitor Tenofovir and entry inhibitor Maraviroc in a humanized mouse model
Milena Veselinovic, Kuo-Hsiung Yang, Jonathan LeCureux, et al.
Antiviral Research
|
December 1, 2016
The FDA-approved drug sofosbuvir inhibits Zika virus infection
Kristen M Bullard-Feibelman, Jennifer Govero, Zhe Zhu, et al.
Virology
|
January 9, 2018
Zika viral infection and neutralizing human antibody response in a BLT humanized mouse model
Kimberly Schmitt, Paige Charlins, Milena Veselinovic, et al.
Journal of Virology
|
November 1, 2016
Development and Characterization of Recombinant Virus Generated from a New World Zika Virus Infectious Clone
James Weger-Lucarelli, Nisha K Duggal, Kristen Bullard-Feibelman, et al.
Journal of Virology
|
March 31, 2017
Erratum for Weger-Lucarelli et al., "Development and Characterization of Recombinant Virus Generated from a New World Zika Virus Infectious Clone"
James Weger-Lucarelli, Nisha K Duggal, Kristen Bullard-Feibelman, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 9) with videos related to
Sort By:
Page
of 1
Methods in Molecular Biology (Clifton, N.J.)
|
December 31, 2015
Modeling HIV-1 Mucosal Transmission and Prevention in Humanized Mice
Milena Veselinovic, Paige Charlins, Ramesh Akkina
Virology
|
July 27, 2012
Topical gel formulation of broadly neutralizing anti-HIV-1 monoclonal antibody VRC01 confers protection against HIV-1 vaginal challenge in a humanized mouse model
Milena Veselinovic, C Preston Neff, Leila R Mulder, et al.
Biosensors & Bioelectronics
|
September 14, 2016
A sensitive DNA capacitive biosensor using interdigitated electrodes
Lei Wang, Milena Veselinovic, Lang Yang, et al.
Virology
|
January 16, 2016
Mucosal tissue pharmacokinetics of the integrase inhibitor raltegravir in a humanized mouse model: Implications for HIV pre-exposure prophylaxis
Milena Veselinovic, Kuo-Hsiung Yang, Craig Sykes, et al.
Virology
|
August 9, 2014
HIV pre-exposure prophylaxis: mucosal tissue drug distribution of RT inhibitor Tenofovir and entry inhibitor Maraviroc in a humanized mouse model
Milena Veselinovic, Kuo-Hsiung Yang, Jonathan LeCureux, et al.
Antiviral Research
|
December 1, 2016
The FDA-approved drug sofosbuvir inhibits Zika virus infection
Kristen M Bullard-Feibelman, Jennifer Govero, Zhe Zhu, et al.
Virology
|
January 9, 2018
Zika viral infection and neutralizing human antibody response in a BLT humanized mouse model
Kimberly Schmitt, Paige Charlins, Milena Veselinovic, et al.
Journal of Virology
|
November 1, 2016
Development and Characterization of Recombinant Virus Generated from a New World Zika Virus Infectious Clone
James Weger-Lucarelli, Nisha K Duggal, Kristen Bullard-Feibelman, et al.
Journal of Virology
|
March 31, 2017
Erratum for Weger-Lucarelli et al., "Development and Characterization of Recombinant Virus Generated from a New World Zika Virus Infectious Clone"
James Weger-Lucarelli, Nisha K Duggal, Kristen Bullard-Feibelman, et al.
Page
of 1